Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat.

Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat.

Bibliographic Details
Main Authors:	Laura M Filkins, George A O'Toole
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-12-01
Series:	PLoS Pathogens
Online Access:	http://europepmc.org/articles/PMC4700991?pdf=render

Similar Items

One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway
by: Fabrice Jean-Pierre, et al.
Published: (2021-04-01)

Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system
by: Fabrice Jean-Pierre, et al.
Published: (2023-01-01)

Transcriptional profiling and genetic analysis of a cystic fibrosis airway-relevant model shows asymmetric responses to growth in a polymicrobial community
by: Christopher A. Kesthely, et al.
Published: (2023-10-01)

Biogeochemical Forces Shape the Composition and Physiology of Polymicrobial Communities in the Cystic Fibrosis Lung
by: Robert A. Quinn, et al.
Published: (2014-05-01)

Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways
by: Rutvij A. Khanolkar, et al.
Published: (2020-12-01)

Model Systems to Study the Chronic, Polymicrobial Infections in Cystic Fibrosis: Current Approaches and Exploring Future Directions
by: George A. O’Toole, et al.
Published: (2021-10-01)

Mild Cystic Fibrosis Lung Disease Is Associated with Bacterial Community Stability
by: Thomas H. Hampton, et al.
Published: (2021-09-01)

<italic toggle="yes">Pseudomonas aeruginosa</italic> Alters <italic toggle="yes">Staphylococcus aureus</italic> Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection
by: Giulia Orazi, et al.
Published: (2017-09-01)

Metabolic Modeling of Cystic Fibrosis Airway Communities Predicts Mechanisms of Pathogen Dominance
by: Michael A. Henson, et al.
Published: (2019-04-01)

Lung function and microbiota diversity in cystic fibrosis
by: Leah Cuthbertson, et al.
Published: (2020-04-01)

Development of the intestinal microbiome in cystic fibrosis in early life
by: Courtney E. Price, et al.
Published: (2023-08-01)

Bacteriocin-mediated competition in cystic fibrosis lung infections.
by: Ghoul, M, et al.
Published: (2015)

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i>
by: Emma Reece, et al.
Published: (2021-07-01)

Bacterial activity in cystic fibrosis lung infections
by: Hockey Peter M, et al.
Published: (2005-06-01)

Development of Complex Models to Study Co- and Polymicrobial Infections and Diseases.
by: Glenn Rall, et al.
Published: (2016-09-01)

Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes
by: Ruchi Yadav, et al.
Published: (2023-09-01)

Epidemiological Features of Chronic Lung Infection in Patients with Cystic Fibrosis
by: I. A. Shaginyan, et al.
Published: (2017-12-01)

Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis
by: Jacob Vieira, et al.
Published: (2022-10-01)

Complex ecological approach to cystic fibrosis respiratory infections
by: Dmitriy V. Alekseev, et al.
Published: (2023-11-01)

Lung Microbiome in Cystic Fibrosis
by: Filippo Scialo, et al.
Published: (2021-01-01)

Imaging of the bacterial interactions in lung co-infection in cystic fibrosis patients
by: Burkaltseva M.V., et al.
Published: (2020-05-01)

Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
by: Katherine E Price, et al.
Published: (2015-01-01)

Current and Emerging Therapies to Combat Cystic Fibrosis Lung Infections
by: Jim Manos
Published: (2021-09-01)

Early-Life Infection in Cystic Fibrosis and Lung Disease Progression
by: Argyri Petrocheilou MD, et al.
Published: (2017-11-01)

Oxidant lung injury in cystic fibrosis
by: Chmiel James, et al.
Published: (2000-11-01)

Prevalence of Polymicrobial Infection in Urethritis
by: Mehmet Sarıer
Published: (2019-09-01)

Hypermutation as an Evolutionary Mechanism for <i>Achromobacter xylosoxidans</i> in Cystic Fibrosis Lung Infection
by: Laura Veschetti, et al.
Published: (2020-01-01)

Innate immunity in cystic fibrosis lung disease.
by: Hartl, D, et al.
Published: (2012)

Management of Multidrug Resistant Infections in Lung Transplant Recipients with Cystic Fibrosis
by: Vazirani J, et al.
Published: (2021-12-01)

Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation
by: Sabine Renner, et al.
Published: (2020-12-01)

Polymicrobial–Host Interactions during Infection
by: Tay, Wei Hong, et al.
Published: (2017)

Concomitant Cryptococcosis and Burkholderia Infection in an Asymptomatic Lung Transplant Patient with Cystic Fibrosis
by: S. Shafaghi, et al.
Published: (2010-10-01)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
by: Kiera H. Harwood, et al.
Published: (2021-07-01)

A Developmental Role of the Cystic Fibrosis Transmembrane Conductance Regulator in Cystic Fibrosis Lung Disease Pathogenesis
by: Elena N. Huang, et al.
Published: (2021-10-01)

PECULIARITIES OF RADIATION DIAGNOSTIC OF LUNGS WITH CYSTIC FIBROSIS
by: Artem Malysh, et al.
Published: (2019-06-01)

Regulation of the Inflammasome by Ceramide in Cystic Fibrosis Lungs
by: Heike Grassmé, et al.
Published: (2014-06-01)

Cystic Fibrosis Lung Disease in the Aging Population
by: Lisa Künzi, et al.
Published: (2021-04-01)

Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies
by: Annalucia Carbone, et al.
Published: (2023-10-01)

Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis
by: Helen Gavillet, et al.
Published: (2022-10-01)

Update on Calcium Signaling in Cystic Fibrosis Lung Disease
by: Alessandro Rimessi, et al.
Published: (2021-03-01)